product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human CD109 Protein, CF
catalog :
4385-CD-050
quantity :
50 ug
price :
541 USD
more info or order :
citations: 1
Reference
Filppu P, Tanjore Ramanathan J, Granberg K, Gucciardo E, Haapasalo H, Lehti K, et al. CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity. JCI Insight. 2021;6: pubmed publisher
product information
brand :
R&D Systems, a Bio-Techne brand
catalog number base :
4385-CD
SKU :
4385-CD-050
product name :
Recombinant Human CD109 Protein, CF
description :
The Recombinant Human CD109 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human CD109 Protein, CF has been validated for the following applications: Binding Activity.
target :
CD109
unit size :
50 ug
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
observed molecular weight :
155-165 kDa, reducing conditions
theoretical molecular weight :
141 kDa
gene symbol :
CD109
details of functionality :
Measured by its ability to bind TGF¿ß1 in a functional ELISA. Finnson, K.W. et al . (2006) FASEB J. 20 :1525. Immobilized rhTGF¿ß1 at 1 µg/mL (100 µL/well) can bind rhCD109 with an apparent KD 0.1 µM.
endotoxin note :
<0.01 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
Q6YHK3
applications :
Binding Activity
product keywords :
4385-CD, rhCD109, hCD109, carrier-free, carrier free, 4385CD, Gov platelet alloantigens, myeloid leukemia, GARP (mouse), GPI-anchored alpha 2 Macroglobulin-related protein (mouse), cytokine, cytokines
source :
NS0-derived Recombinant Human CD109 Protein, CF
USD :
525
USD 2025 :
541 USD
alt names :
150 kDa TGF-beta-1-binding protein, activated T-cell marker CD109, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7, CD109, CD109 antigen, CD109 antigen (Gov platelet alloantigens), CD109 molecule, CPAMD7, CPAMD7r150, DKFZp762L1111, FLJ38569, FLJ41966, Gov platelet alloantigens, p180, Platelet-specific Gov antigen, RP11-525G3.1
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.